cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

McLean, John W., Tomlinson, James E., Kuang, Wun-Jing, Eaton, Dan L., Chen, Ellson Y., Fless, Gunther M., Scanu, Angelo M., Lawn, Richard M.·1987·Nature
DOI 10.1038/330132a0

Cited by (1,002)

Items 401–500 of 1,002

  1. Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes
    Steven M. Haffner, Katherine R. Tuttle, David L. Rainwater · 1992 · Metabolism
  2. Small‐molecule modulators of zymogen activation in the fibrinolytic and coagulation systems
    Keiji Hasumi, Shingo Yamamichi, Tomotaka Harada · 2010 · FEBS Journal
  3. Antisense Technology: An Emerging Platform for Cardiovascular Disease Therapeutics
    Richard G. Lee, Jeff R. Crosby, Brenda F. Baker, Mark J. Graham, Rosanne M. Crooke · 2013 · Journal of Cardiovascular Translational Research
  4. Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease
    Yonghong Li, May M. Luke, Dov Shiffman, James J. Devlin · 2011 · Circulation Cardiovascular Genetics
  5. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus
    Eriko Morishita, Hidesaku Asakura, Hiroshi Jokaji, Masanori Saito, Chika Uotani, Ichiro Kumabashiri, Masahide Yamazaki, Keiji Aoshima, Takuma Hashimoto, Tamotsu Matsuda · 1996 · Atherosclerosis
  6. Recent advances in demystifying the metabolism of lipoprotein(a)
    Kévin Chemello, Dick C. Chan, Gilles C. Lambert, Gerald Francis Watts · 2022 · Atherosclerosis
  7. Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children
    Neil A. Goldenberg, Timothy J. Bernard, J. Hillhouse · 2013 · Haematologica
  8. Lipoprotein (a) in a randomly selected 25?64 year old population: The Northern Sweden Monica study
    Lisbeth Slunga · 1993 · Journal of Clinical Epidemiology
  9. Lipoprotein (a): Its Role in Childhood Thromboembolism
    Ulrike Nowak‐Göttl, Ottfried Debus, Martina Findeisen · 1997 · PEDIATRICS
  10. A transcribed gene, containing a variable number of tandem repeats, codes for a human epithelial tumor antigen
    Mara Hareuveni, Ilan Tsarfaty, Joseph Z. Zaretsky et al. · 1990 · European Journal of Biochemistry
  11. Alterations of lipoprotein(a) in patients with diabetic nephropathy
    Tadayoshi Takegoshi, Toshihiro Haba, Jun-ichi Hirai · 1990 · Atherosclerosis
  12. LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics
    Erfan Tasdighi, Rishav Adhikari, Omar Almaadawy, Thorsten Martin Leucker, Michael Joseph Blaha · 2023 · The Annual Review of Pharmacology and Toxicology
  13. Lipoprotein(a): biology and clinical importance.
    Sally P.A. McCormick · 2004 · PubMed Central
  14. Apolipoprotein(a) inhibits the conversion of Glu‐plasminogen to Lys‐plasminogen: a novel mechanism for lipoprotein(a)‐mediated inhibition of plasminogen activation
    Nicole T. Feric, Michael B. Boffa, S. M. Johnston · 2008 · Journal of Thrombosis and Haemostasis
  15. Lipid and Apolipoprotein Predictors of Atherosclerosis in Youth: Apolipoprotein Concentrations Do Not Materially Improve Prediction of Arterial Lesions in PDAY Subjects
    Rainwater, David L., McMahan, C. Alex, Malcom, Gray T., Scheer, W. Douglas, Roheim, Paul S., McGill, Henry C., Strong, Jack P. · 1999 · Arteriosclerosis, Thrombosis, and Vascular Biology
  16. New and Emerging Risk Factors for Coronary Heart Disease
    Ehimare Akhabue, Jeffrey P. Thiboutot, Jeh-Wei Cheng, Stamatios Lerakis, Timothy J. Vittorio, Georgios Christodoulidis, Kathleen M. Grady, Constantine E. Kosmas · 2013 · The American Journal of the Medical Sciences
  17. Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein
    Tjark Reblin, Andreas Niemeier, Nicolette Meyer · 1997 · Journal of Lipid Research
  18. Immune Tolerance in Mytilus galloprovincialis Hemocytes After Repeated Contact With Vibrio splendidus
    Magalí Rey-Campos, Rebeca Moreira, Marco Gerdol, Alberto Pallavicini, Beatriz Novoa, Antonio J. Figueras · 2019 · Frontiers in Immunology
  19. Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism
    Andelko Hrzenjak, Saša Frank, WO Xing-de · 2003 · Biochemical Journal
  20. The role of fibrinogen and fibrinolysis in peripheral arterial disease
    Kosmas I. Paraskevas, Daryll Baker, George E. Vrentzos, Dimitri P. Mikhailidis · 2007 · Thrombosis Research
  21. High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins
    Matthias Schneider, Joseph Lee Witztum, Stephen G. Young, E H Ludwig, Elizabeth R. Miller, Sotirios Tsimikas, Linda K. Curtiss, Santica M. Marcovina, John M. Taylor, Richard M. Lawn et al. · 2005 · Journal of Lipid Research
  22. Concentrations of Lp(a) in black and white young adults: Relations to risk factors for cardiovascular disease
    Barbara V. Howard, Ngoc‐Anh Le, John D. Belcher, John M. Flack, David R. Jacobs, Cora Elizabeth Lewis, Santica M. Marcovina, Laura L. Perkins · 1994 · Annals of Epidemiology
  23. Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein 1 1Edited by R. Huber
    Jorge L. Ríos-Steiner, Monica Schenone, Igor Mochalkin, Alexander Tulinsky, Francis J. Castellino · 2001 · Journal of Molecular Biology
  24. Lipoprotein(a) Levels and Recurrent Vascular Events After First Ischemic Stroke
    Kristin Sophie Lange, Alexander H. Nave, Thomas Liman, Ulrike Grittner, Matthias Endres, Martin Ebinger · 2016 · Stroke
  25. Metabolism of Apo(a) and ApoB100 of Lipoprotein(a) in Women: Effect of Postmenopausal Estrogen Replacement1
    Wanfang Su, Hannia Campos, Helena Judge, Brian W. Walsh, Frank M. Sacks · 1998 · The Journal of Clinical Endocrinology & Metabolism
  26. Expression of a Recombinant Apolipoprotein(a) in HepG2 Cells
    Denise K. Bonen, AnnaliseM. L. Hausman, Christos Hadjiagapiou · 1997 · Journal of Biological Chemistry
  27. Linkage between the loci for the Lp(a) lipoprotein (LP) and plasminogen (PLG)
    LOWELL R. WEITKAMP, Sally A. Guttormsen, Jerome S. Schultz · 1988 · Human Genetics
  28. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease
    Giampaolo Niccoli, Diana Cin, Giancarla Scalone, Mario Panebianco, Sofia Abbolito, Nicola Cosentino, Francesca Jacoangeli, Hesham Refaat, Giovanna Gallo, Gerardo Salerno et al. · 2016 · Atherosclerosis
  29. Molecular Biomarkers for Cardiometabolic Disease: Risk Assessment in Young Individuals
    Usman A. Tahir, Robert Edgardo Gerszten · 2023 · Circulation Research
  30. Aspirin Reduces Apolipoprotein(a) (Apo(a)) Production in Human Hepatocytes by Suppression of Apo(a) Gene Transcription
    Ayako Kagawa, Hiroyuki Azuma, Masashi Akaike, Yasuhiko Kanagawa, Toshio Matsumoto · 1999 · Journal of Biological Chemistry
  31. Interaction of lipoprotein Lp[a] with the B/E-receptor: a study using isolated bovine adrenal cortex and human fibroblast receptors.
    Ernst Steyrer, GM Kostner · 1990 · Journal of Lipid Research
  32. A single point mutation (Trp72 → Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a)
    Angelo M. Scanu, Ditta Pfaffinger, John C. Lee, Janet Hinman · 1994 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  33. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure
    Leonardo Alberto Sechi, Laura Zingaro, Cristiana Catena · 1999 · Kidney International
  34. Annexin II: A Novel Mediator of Cell Surface Plasmin Generation
    Katherine A. Hajjar, Jill S. Menell · 1997 · Annals of the New York Academy of Sciences
  35. Binding of recombinant apolipoprotein(a) to extracellular matrix proteins.
    Ytje Y. van der Hoek, Waheed Sangrar, Graham P. Côté · 1994 · Arteriosclerosis and Thrombosis A Journal of Vascular Biology
  36. Elevated Plasma Lipoprotein(a) Is Associated With Coronary Artery Disease in Patients With Chronic Stable Angina Pectoris 11Dr. Cox is supported by a Fellowship Grant from the British Heart Foundation, London.
    Raúl A. Schwartzman, Ian D. Cox, Jan Dominik Poloniecki, Robert E. Crook, Carol A. Seymour, Juan Carlos Kaski · 1998 · Journal of the American College of Cardiology
  37. The collagen‐binding site of type‐II units of bovine seminal fluid protein PDC‐109 and fibronectin
    László Bányai, Mária Trexler, Sándor KONCZ · 1990 · European Journal of Biochemistry
  38. Risk Factors of Atherosclerotic Diseases - Executive Summary of Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases for Japanese
    Tamio Teramoto, Junichi Sasaki, Hirotsugu Ueshima, Genshi Egusa, Makoto Kinoshita, Kazuaki Shimamoto, Hiroyuki Daida, Sadatoshi Biro, Kazuhiko Hirobe, Tohru Funahashi et al. · 2007 · Journal of Atherosclerosis and Thrombosis
  39. Estrogen Modulation of Apolipoprotein(a) Expression
    Dario Boffelli, Deborah A. Zajchowski, Zhuoying Yang · 1999 · Journal of Biological Chemistry
  40. The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans
    Thomas Demant, Katja Seeberg, Andrea Bedynek, Dietrich Seidel · 2001 · Atherosclerosis
  41. Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis
    Katsuyuki Nakajima, Akira Tanaka · 2018 · Clinica Chimica Acta
  42. Immunolocalization of Lipoprotein(a) in Wounded Tissues
    Yoko Yano, Kuniyasu Shimokawa, Yume Okada · 1997 · Journal of Histochemistry & Cytochemistry
  43. Hypercoagulable states and central retinal vein occlusion
    J. Michael Lahey, John J. Kearney, Murat Tunç · 2003 · Current Opinion in Pulmonary Medicine
  44. Recent observations on the role of hemostatic determinants in the development of the atherothrombotic plaque
    LeRoy E. Rabbani, Joseph Loscalzo · 1994 · Atherosclerosis
  45. Tetranectin immunoreactivity in normal human tissues
    L. Christensen, Inge Haunstrup Clemmensen · 1989 · Histochemistry and Cell Biology
  46. Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance
    Gösta H. Dahlén, Hans C. Stenlund · 1997 · Clinical Genetics
  47. Binding of tissue-type plasminogen activator to lysine, lysine analogs, and fibrin fragments
    Gerard A W de Munk, Martien P. M. Caspers, Glenn T.G. Chang · 1989 · Biochemistry
  48. The current status of lipoprotein (a) in pregnancy: A literature review
    Angela Fanshawe, Michael Ibrahim · 2012 · Journal of Cardiology
  49. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a)
    Cristiana Catena, Marileda Novello, Roberta Lapenna · 2005 · Journal of Hypertension
  50. Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
    Hayato Tada, Masayuki Takamura, Masa‐aki Kawashiri · 2019 · Journal of Atherosclerosis and Thrombosis
  51. Apolipoprotein(a) Attenuates Endogenous Fibrinolysis in the Rabbit Jugular Vein Thrombosis Model In Vivo
    Bart J. Biemond, Philip W. Friederich, Marlys L. Koschinsky · 1997 · Circulation
  52. Feedback Mechanism of Focal Vascular Lesion Formation in Transgenic Apolipoprotein(a) Mice
    Richard M. Lawn, Andrew D. Pearle, Lawrence L. Kunz, Edward M. Rubin, Jill Reckless, James C. Metcalfe, David J. Grainger · 1996 · Journal of Biological Chemistry
  53. Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women ≥55 Years of Age
    Satoshi Sunayama, Hiroyuki Daida, Hiroshi Mokuno, Hiroshi Miyano, Hisashi Yokoi, Young Joon Lee, Hidehiko Sakurai, Hiroshi Yamaguchi · 1996 · Circulation
  54. Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity
    Joëlle Thillet, Chantal Doucet, John Chapman, Bernard Herbeth, Daniel Cohen, Laurence Faure-Delanef · 1998 · Atherosclerosis
  55. Role of Lipoprotein (a) and TGF-β1 in Atherosclerosis of Hemodialysis Patients
    Masahisa Fujisawa, Reiko Haramaki, Hiroshi Miyazaki · 2000 · Journal of the American Society of Nephrology
  56. Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus
    Kyoko Hirata, Shuichi Kikuchi, Keijiro Saku · 1993 · Kidney International
  57. Influence of plasma lipoprotein(a) levels on coronary vasomotor response to acetylcholine
    Yukio Tsurumi, Hirotaka Nagashima, Kenichiro Ichikawa · 1995 · Journal of the American College of Cardiology
  58. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study
    Lionel Brazier, Laurence Tiret, Gérald Luc, Dominique Arveiler, Jean Bernard Ruidavets, Alun Evans, John Chapman, François Cambien, Joëlle Thillet · 1999 · Atherosclerosis
  59. Divergent evolution of part of the involucrin gene in the hominoids: unique intragenic duplications in the gorilla and human.
    Jeffrey Teumer, H Green · 1989 · Proceedings of the National Academy of Sciences
  60. Fibrinolysis and atherosclerosis: An update
    Anders Hamsten, Per Olof Eriksson · 1994 · Fibrinolysis and Proteolysis
  61. Screening and identification of five serum proteins as novel potential biomarkers for cured pulmonary tuberculosis
    Chong Wang, Liliang Wei, Liying Shi et al. · 2015 · Scientific Reports
  62. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels
    Wensheng Lu, Yi‐Chiao Cheng, Kong Y. Chen, H. Wang, Glenn S. Gerhard, Christopher D. Still, Xin Chu, Runxu Yang, A. Parihar, Jeffery R. O’Connell et al. · 2015 · Human Molecular Genetics
  63. A comprehensive map of single-base polymorphisms in the hypervariable LPA kringle IV type 2 copy number variation region
    Stefan Coassin, Sebastian Schönherr, Hansi Weißensteiner, Gertraud Erhart, Lukas Forer, Jamie Lee Losso, Claudia Lamina, Margot Haun, Gerd Utermann, Bernhard Paulweber et al. · 2018 · Journal of Lipid Research
  64. Lipoprotein (a) levels in children and young adults: the influence of physical activity. The Cardiovascular Risk in Young Finns Study
    SIMO P. TAIMELA, JSA Viikari, KVK Porkka · 1994 · Acta Paediatrica
  65. Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes
    Juan Carlos Ruiz, Joëlle Thillet, Thierry Huby, Richard William James, Daniele Erlich, Philippe Flandre, Philippe Froguel, John Chapman, Philippe Passa · 1994 · Diabetologia
  66. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
    Thomas Cooke, Richard G. Sheahan, David P. Foley · 1994 · Circulation
  67. Structural requirements of apo-a for the lipoprotein-a assembly
    Saša Frank, Srdan Durovic, Gerhard Max Kostner · 1994 · Biochemical Journal
  68. Effectiveness of Diet and Drugs in the Treatment of Patients with Elevated Lp(a) Levels
    H. Bryan Brewer · 1990 · Elsevier eBooks
  69. Effects of physical activity and diet on lipoprotein(a)
    LAUREL TRAEGER MACKINNON, Lyle M. Hubinger, Frank Lepre · 1997 · Medicine & Science in Sports & Exercise
  70. Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9
    Rocco Romagnuolo, Corey A. Scipione, Santica M. Marcovina, Matthew Gemin, Nabil Georges Seidah, Michael B. Boffa, Marlys L. Koschinsky · 2017 · PLoS ONE
  71. New Frontiers in Lp(a)-Targeted Therapies
    Matthew J. Borrelli, Amer Youssef, Michael B. Boffa, Marlys L. Koschinsky · 2019 · Trends in Pharmacological Sciences
  72. Apolipoprotein(a) Synthesis and Secretion from Hepatoma Cells Is Coupled to Triglyceride Synthesis and Secretion
    Fatiha Nassir, Denise K. Bonen, Nicholas O. Davidson · 1998 · Journal of Biological Chemistry
  73. Relation of Apo(a) Size to Carotid Atherosclerosis in an Elderly Multiethnic Population
    Furcy Paultre, Catherine H. Tuck, Bernadette M Boden-Albala, Douglas E. Kargman, Elizabeth Todd, Jeffrey Jones, Myunghee Cho Paik, Ralph L. Sacco, Lars Berglund · 2002 · Arteriosclerosis Thrombosis and Vascular Biology
  74. Production of lipoprotein(a) by primary baboon hepatocytes
    David L. Rainwater, Robert E. Lanford · 1989 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
  75. Fish Intake, Independent of Apo(a) Size, Accounts for Lower Plasma Lipoprotein(a) Levels in Bantu Fishermen of Tanzania
    Santica M. Marcovina, Hal Kennedy, Gabriele Bittolo Bon, Giuseppe Cazzolato, Claudio Galli, Edoardo Casiglia, Massimo Puato, Paolo Pauletto · 1999 · Arteriosclerosis Thrombosis and Vascular Biology
  76. Lipoprotein(a) levels in chronic renal disease states, dialysis and transplantation
    Ashley Bruce Irish, Leon A. Simons, Elliott Savdie · 1992 · Australian and New Zealand Journal of Medicine
  77. Characterization of the cDNA coding for mouse plasminogen and localization of the gene to mouse chromosome 17
    Sandra J. Friezner Degen, Sheila M. Bell, Lorie A. Schaefer · 1990 · Genomics
  78. Lipoprotein(a): A Promising Marker for Residual Cardiovascular Risk Assessment
    Anping Cai, Liwen Li, Ying Zhang, Yujin Mo, Weiyi Mai, Yingling Zhou · 2013 · Disease Markers
  79. Lipids in liver transplant recipients
    Anna Hüsing, Iyad Kabar, Hartmut Schmidt · 2016 · World Journal of Gastroenterology
  80. Oxidized phospholipids and lipoprotein-associated phospholipase A2 as important determinants of Lp(a) functionality and pathophysiological role
    D. Alexandros · 2016 · Journal of Biomedical Research
  81. Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study
    Federica Fogacci, Arrigo F.G. Cicero, Sergio D’Addato, L. D'Agostini, Martina Rosticci, Marina Giovannini, Enrico Bertagnin, Claudio Borghi · 2016 · European Journal of Internal Medicine
  82. Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein
    Marlys L. Koschinsky · 2005 · Current Atherosclerosis Reports
  83. Presecretory degradation of apolipoprotein[a] is mediated by the proteasome pathway
    Ann L. White, Bernadette Guerra, Jin Wang, Robert E. Lanford · 1999 · Journal of Lipid Research
  84. Interaction of Tetranectin with Sulphated Polysaccharides and Trypan Blue
    Inge Haunstrup Clemmensen · 1989 · Scandinavian Journal of Clinical and Laboratory Investigation
  85. Structure of bovine prothrombin fragment 1 refined at 2.25 Å resolution
    T. P. Seshadri, Alexander Tulinsky, Ewa Skrzypczak‐Jankun · 1991 · Journal of Molecular Biology
  86. Antisense Oligonucleotides Targeting Lipoprotein(a)
    Anne Langsted, Børge Grønne Nordestgaard · 2019 · Current Atherosclerosis Reports
  87. Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis?
    Ioannis E. Κoutroubakis, Niki E. Malliaraki, Emmanouel M. Vardas · 2001 · European Journal of Gastroenterology & Hepatology
  88. Lipoprotein(a): Genotype–Phenotype Relationship and Impact on Atherogenic Risk
    Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, Tina P. Tran, Lars Berglund · 2011 · Metabolic Syndrome and Related Disorders
  89. Sequence Variation within the KIV-2 Copy Number Polymorphism of the Human LPA Gene in African, Asian, and European Populations
    Asma Noureen, Friedrich Fresser, Gerd Utermann, Konrad Schmidt · 2015 · PLoS ONE
  90. Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a)
    Margaret R. Diffenderfer, Stefania Lamon‐Fava, Santica M. Marcovina, P. Hugh R. Barrett, Julian Lel, Gregory G. Dolnikowski, Lars Berglund, Ernst J. Schaefer · 2015 · Metabolism
  91. Molecular cloning and characterization of Kremen, a novel kringle-containing transmembrane protein
    Takahiro Nakamura, Takahiro Nakamura, Shunsuke Aoki · 2001 · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
  92. A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a)
    Walther Parson, H.G. Kraft, Harald Niederstätter · 2004 · Human Mutation
  93. Serum lipoprotein(a) concentrations and alcohol consumption in hypertension
    Cristiana Catena, Marileda Novello, Luciana Dotto · 2003 · Journal of Hypertension
  94. Kinetic analysis of the effects of heparin and lipoproteins on tissue plasminogen activator mediated plasminogen activation
    Jay M. Edelberg, Salvatore Vincent Pizzo · 1990 · Biochemistry
  95. Proteoglycans Contribution to Association of Lp(a) and LDL With Smooth Muscle Cell Extracellular Matrix
    Ulf Lundstam, Eva Hurt‐Camejo, Gun Olsson, Peter Sartipy, Germán Camejo, Olov Wiklund · 1999 · Arteriosclerosis Thrombosis and Vascular Biology
  96. A PIVOTAL ROLE FOR TGF‐β* IN ATHEROGENESIS?
    David J. Grainger, James C. Metcalfe · 1995 · Biological reviews/Biological reviews of the Cambridge Philosophical Society
  97. Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a]
    Celina Edelstein, James A. Italia, Olga Klezovitch · 1996 · Journal of Lipid Research
  98. Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population
    J.D. Kark, Christoph Sandholzer, Yechiel Friedlander, Gerd Utermann · 1993 · Atherosclerosis
  99. Kringle-dependent structural and functional polymorphism of apolipoprotein (a)
    Angelo M. Scanu, Celina Edelstein · 1995 · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
  100. Lipoprotein (a): The link between impaired fibrinolysis and atherosclerosis
    Jay M. Edelberg, Salvatore Vincent Pizzo · 1991 · Fibrinolysis and Proteolysis